Acrisure Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,364
Closed -$230K 35
2023
Q1
$230K Buy
+2,364
New +$230K 0.23% 205